| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP Of Clinical Development
1 company
Goldberg Y. Paul is a VP Of Clinical Development at Xenon Pharmaceuticals Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $329K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2015 | XENE Xenon Pharmaceuticals Inc. | VP Of Clinical Development | Sale+OE | 22,149 | $8.88 | $196,664.31 | -32.5% |